Showing results (61-70 of 78) with videos related to
Sort By:
Pageof 8
The Journal of Infectious Diseases|February 18, 1998
Trends in antimicrobial drug use in the community--France, 1981-1992D Guillemot, P Maison, C Carbon, et al.JAMA|February 12, 1998
Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniaeD Guillemot, C Carbon, B Balkau, et al.Presse Medicale (Paris, France : 1983)|December 10, 2003
[Survey on the treatment of hospitalised community-acquired lower respiratory tract infections]P Villani, F Barlesi, A Paraponaris, et al.Revue D'Epidemiologie Et De Sante Publique|March 26, 2011
Feedback and lessons from the prescription of rimonabant, a drug to be used under strict guidelines, in southeastern France, March 2007 through June 2008M Jardin, S Cortaredona, A Bocquier, et al.Thrombosis and Haemostasis|February 11, 2000
Fluvastatin decreases soluble thrombomodulin in cardiac transplant recipientsP Ambrosi, M F Aillaud, G Habib, et al.Health Policy (Amsterdam, Netherlands)|August 18, 2004
Delivering generics without regulatory incentives? Empirical evidence from French general practitioners about willingness to prescribe international non-proprietary namesA Paraponaris, P Verger, B Desquins, et al.Therapie|July 1, 1997
[Clinical evaluation: from intermediate to surrogate criteria]J P Boissel, L Perret, G Bouvenot, et al.Annales De Cardiologie Et D'Angeiologie|January 31, 2003
[Homocysteine and coronary events in coronary disease patients]P Ambrosi, A Barlatier, A Artaud-Navarro, et al.Annales De Cardiologie Et D'Angeiologie|October 17, 1998
[ECG anomalies and axis deviations in heart transplant recipients: MRI studies]P Ambrosi, G Habib, R Gélisse, et al.Pharmacoeconomics|December 8, 1997
Medico-economic analysis of diacerein with or without standard therapy in the treatment of osteoarthritisF Fagnani, G Bouvenot, J P Valat, et al.Pageof 8